Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Dexibuprofen | hsa00030 | Pentose phosphate pathway | 5.07E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Dexibuprofen | hsa00071 | Fatty acid degradation | 4.66E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Dexibuprofen | hsa00190 | Oxidative phosphorylation | 1.39E-03 | 4 | Q16718, Q13488, P36542, O14521 | NDUFA5, TCIRG1, ATP5C1, SDHD | More | | Dexibuprofen | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Dexibuprofen | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Dexibuprofen | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Dexibuprofen | hsa00500 | Starch and sucrose metabolism | 1.97E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Dexibuprofen | hsa00510 | N-Glycan biosynthesis | 1.00E-02 | 2 | O94777, Q9BVK2 | DPM2, ALG8 | More | | Dexibuprofen | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Dexibuprofen | hsa00561 | Glycerolipid metabolism | 3.09E-02 | 2 | P14550, Q86XP1 | AKR1A1, DGKH | More | | Dexibuprofen | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 3.47E-03 | 2 | O94777, Q14442 | DPM2, PIGH | More | | Dexibuprofen | hsa00565 | Ether lipid metabolism | 2.31E-04 | 2 | Q9Y6K0, Q8N661 | CEPT1, TMEM86B | More | | Dexibuprofen | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Dexibuprofen | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Dexibuprofen | hsa00600 | Sphingolipid metabolism | 4.63E-04 | 6 | Q9BX95, Q96G23, O14494, Q06136, P06280, Q86VZ5 | SGPP1, LASS2, PLPP1, FVT1, GLA, SGMS1 | More | | Dexibuprofen | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.29E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Dexibuprofen | hsa00785 | Lipoic acid metabolism | 4.32E-02 | 1 | Q9Y234 | LIPT1 | More | | Dexibuprofen | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Dexibuprofen | hsa00970 | Aminoacyl-tRNA biosynthesis | 6.79E-06 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Dexibuprofen | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Dexibuprofen | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Dexibuprofen | hsa00983 | Drug metabolism - other enzymes | 2.58E-04 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Dexibuprofen | hsa01100 | Metabolic pathways | 6.91E-04 | 15 | Q9Y234, Q6ZQY3, P20839, O94777, Q9Y6K0, Q86XP1, P14550, Q9UHK6, Q86VZ5, Q96G23, Q9BVK2, Q14442, Q06055, Q99437, Q9NVH6 | LIPT1, GADL1, IMPDH1, DPM2, CEPT1, DGKH, AKR1A1, AMACR, SGMS1, LASS2, ALG8, PIGH, ATP5G2, ATP6V0B, TMLHE | More | | Dexibuprofen | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Dexibuprofen | hsa03013 | RNA transport | 3.81E-06 | 16 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, P78345, Q14240, Q9BZI7, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, RPP38, EIF4A2, UPF3B, TACC3, FMR1, FXR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14980 | XPO1 | Exportin-1 | 0.799 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.888 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.956 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.771 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.853 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.72 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.925 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P61326 | MAGOH | Protein mago nashi homolog | 0.761 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.774 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.883 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.854 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.751 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.708 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.79 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.844 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.734 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.869 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.715 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.837 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.77 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.793 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.852 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.819 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.849 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.764 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.812 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.891 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.863 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.798 |
| Dexibuprofen | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Dexibuprofen | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Dexibuprofen | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Dexibuprofen | hsa03060 | Protein export | 4.22E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Dexibuprofen | hsa03450 | Non-homologous end-joining | 4.32E-02 | 1 | Q9NP87 | POLM | More | | Dexibuprofen | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Dexibuprofen | hsa04015 | Rap1 signaling pathway | 1.66E-03 | 11 | P20827, P49767, Q96FS4, P11215, P25116, Q8TEU7, Q13009, Q7LDG7, P42338, P08514, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, RASGRP2, PIK3CB, ITGA2B, PLCG1 | More | | Dexibuprofen | hsa04020 | Calcium signaling pathway | 1.39E-02 | 4 | Q16566, Q15746, P25116, P49767 | CAMK4, MYLK, F2R, VEGFC | More | | Dexibuprofen | hsa04060 | Cytokine-cytokine receptor interaction | 1.74E-04 | 17 | P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P19875, P18510, P01730, Q93038 | IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CXCL2, IL1RN, CD4, TNFRSF25 | More | | Dexibuprofen | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.97E-06 | 11 | Q8NHW4, P09341, P19875, P25024, P25025, P61073, P47992, Q9UBD3, Q13651, P14784, P01375 | CCL4L2, CXCL1, CXCL2, CXCR1, CXCR2, CXCR4, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Dexibuprofen | hsa04062 | Chemokine signaling pathway | 1.25E-05 | 14 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Dexibuprofen | hsa04064 | NF-kappa B signaling pathway | 1.35E-10 | 21 | P10415, O00463, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, P67870, Q16548, P07948, P06239, Q13315, P63279, P24522, O75293, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, TRAF5, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, CSNK2B, BCL2A1, LYN, LCK, ATM, UBE2I, GADD45A, GADD45B, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P24158 | PRTN3 | Myeloblastin | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.787 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P24158 | PRTN3 | Myeloblastin | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.8 | P08311 | CTSG | Cathepsin G | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.853 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P51124 | GZMM | Granzyme M | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.886 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P01584 | IL1B | Interleukin-1 beta | 0.762 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P24158 | PRTN3 | Myeloblastin | Q04759 | PRKCQ | Protein kinase C theta type | -0.845 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P24158 | PRTN3 | Myeloblastin | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.733 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P67870 | CSNK2B | Casein kinase II subunit beta | 0.709 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P24158 | PRTN3 | Myeloblastin | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.802 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | P51124 | GZMM | Granzyme M | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.76 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.702 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P24158 | PRTN3 | Myeloblastin | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.772 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 | P51124 | GZMM | Granzyme M | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.78 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P24158 | PRTN3 | Myeloblastin | P09341 | CXCL1 | Growth-regulated alpha protein | 0.751 | P51124 | GZMM | Granzyme M | P09341 | CXCL1 | Growth-regulated alpha protein | -0.733 | P08311 | CTSG | Cathepsin G | P09341 | CXCL1 | Growth-regulated alpha protein | 0.877 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P51124 | GZMM | Granzyme M | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.739 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 | P51124 | GZMM | Granzyme M | Q06643 | LTB | Lymphotoxin-beta | 0.811 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.763 |
| Dexibuprofen | hsa04071 | Sphingolipid signaling pathway | 1.14E-04 | 7 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Dexibuprofen | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Dexibuprofen | hsa04080 | Neuroactive ligand-receptor interaction | 1.96E-04 | 9 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1, ADRB2 | More | | Dexibuprofen | hsa04120 | Ubiquitin mediated proteolysis | 2.89E-02 | 2 | O95071, P0CG47 | UBR5, UBB | More | | Dexibuprofen | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Dexibuprofen | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | | Dexibuprofen | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Dexibuprofen | hsa04145 | Phagosome | 3.04E-07 | 10 | Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Dexibuprofen | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Dexibuprofen | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Dexibuprofen | hsa04210 | Apoptosis | 2.63E-03 | 9 | Q13315, P10415, O76075, P01375, P24522, Q16548, P43234, P18848, Q14643 | ATM, BCL2, DFFB, TNF, GADD45A, BCL2A1, CTSO, ATF4, ITPR1 | More | | Dexibuprofen | hsa04213 | Longevity regulating pathway - multiple species | 3.66E-03 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Dexibuprofen | hsa04217 | Necroptosis | 3.28E-05 | 10 | P01568, Q13489, Q13546, P07900, P15104, P05141, P01584, P0C0S5, Q6FI13, Q13557 | IFNA21, BIRC3, RIPK1, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, CAMK2D | More | | Dexibuprofen | hsa04260 | Cardiac muscle contraction | 4.49E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | | Dexibuprofen | hsa04330 | Notch signaling pathway | 3.09E-02 | 2 | P49768, P78504 | PSEN1, JAG1 | More | | Dexibuprofen | hsa04340 | Hedgehog signaling pathway | 3.16E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Dexibuprofen | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Dexibuprofen | hsa04371 | Apelin signaling pathway | 1.39E-03 | 9 | P63218, P50151, Q8WYR1, Q15746, Q14814, Q14344, Q13485, P84022, Q16566 | GNG5, GNG10, PIK3R5, MYLK, MEF2D, GNA13, SMAD4, SMAD3, CAMK4 | More | | Dexibuprofen | hsa04390 | Hippo signaling pathway | 5.79E-03 | 4 | P04628, Q9UJU2, O43623, Q13489 | WNT1, LEF1, SNAI2, BIRC3 | More | | Dexibuprofen | hsa04514 | Cell adhesion molecules | 2.43E-02 | 3 | P16109, P29965, O00501 | SELP, CD40LG, CLDN5 | More | | Dexibuprofen | hsa04530 | Tight junction | 6.92E-04 | 6 | Q8TEU7, P16989, P56750, O00501, Q92974, Q14247 | RAPGEF6, CSDA, CLDN17, CLDN5, ARHGEF2, CTTN | More | | Dexibuprofen | hsa04611 | Platelet activation | 3.72E-04 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Dexibuprofen | hsa04612 | Antigen processing and presentation | 6.76E-08 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Dexibuprofen | hsa04613 | Neutrophil extracellular trap formation | 2.89E-05 | 17 | P16109, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, P21730, P08514, P21462, P07359 | SELP, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, C5AR1, ITGA2B, FPR1, GP1BA | More | | Dexibuprofen | hsa04623 | Cytosolic DNA-sensing pathway | 1.41E-04 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Dexibuprofen | hsa04640 | Hematopoietic cell lineage | 1.39E-05 | 13 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Dexibuprofen | hsa04650 | Natural killer cell mediated cytotoxicity | 5.22E-11 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P49863 | GZMK | Granzyme K | P01375 | TNF | Tumor necrosis factor | -0.8 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.748 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.751 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | P24158 | PRTN3 | Myeloblastin | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.816 | P51124 | GZMM | Granzyme M | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.743 | P49863 | GZMK | Granzyme K | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.899 | P08311 | CTSG | Cathepsin G | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.92 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P24158 | PRTN3 | Myeloblastin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.729 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P51124 | GZMM | Granzyme M | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.834 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.715 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P24158 | PRTN3 | Myeloblastin | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.732 | P49863 | GZMK | Granzyme K | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.809 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | P24158 | PRTN3 | Myeloblastin | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.76 | P51124 | GZMM | Granzyme M | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.713 | P49863 | GZMK | Granzyme K | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.96 | P08311 | CTSG | Cathepsin G | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.875 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.913 | P49863 | GZMK | Granzyme K | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.775 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.714 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P24158 | PRTN3 | Myeloblastin | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.77 | P49863 | GZMK | Granzyme K | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.714 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P24158 | PRTN3 | Myeloblastin | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.77 | P49863 | GZMK | Granzyme K | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 |
| Dexibuprofen | hsa04657 | IL-17 signaling pathway | 8.16E-05 | 9 | P07900, O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Dexibuprofen | hsa04658 | Th1 and Th2 cell differentiation | 6.96E-16 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P49863 | GZMK | Granzyme K | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.848 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P51124 | GZMM | Granzyme M | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.755 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P51124 | GZMM | Granzyme M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.887 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 | P51124 | GZMM | Granzyme M | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.849 | P49863 | GZMK | Granzyme K | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.704 |
| Dexibuprofen | hsa04659 | Th17 cell differentiation | 3.10E-12 | 17 | Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P51124 | GZMM | Granzyme M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.887 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P51124 | GZMM | Granzyme M | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.886 | P49863 | GZMK | Granzyme K | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.722 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P51124 | GZMM | Granzyme M | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.755 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 |
| Dexibuprofen | hsa04660 | T cell receptor signaling pathway | 1.60E-11 | 17 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49863 | GZMK | Granzyme K | P01375 | TNF | Tumor necrosis factor | -0.8 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P51124 | GZMM | Granzyme M | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.834 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P49863 | GZMK | Granzyme K | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.872 | P08311 | CTSG | Cathepsin G | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.705 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | P49863 | GZMK | Granzyme K | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.952 | P08311 | CTSG | Cathepsin G | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.722 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P49863 | GZMK | Granzyme K | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.784 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.719 | P49863 | GZMK | Granzyme K | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.793 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.889 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.861 | P49863 | GZMK | Granzyme K | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.716 |
| Dexibuprofen | hsa04662 | B cell receptor signaling pathway | 5.04E-04 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Dexibuprofen | hsa04664 | Fc epsilon RI signaling pathway | 8.44E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Dexibuprofen | hsa04666 | Fc gamma R-mediated phagocytosis | 2.42E-02 | 5 | P23528, P06396, O14494, P14598, P17252 | CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Dexibuprofen | hsa04668 | TNF signaling pathway | 3.19E-02 | 7 | P01375, O00463, Q16539, P09341, P20749, Q13077, P14780 | TNF, TRAF5, MAPK14, CXCL1, BCL3, TRAF1, MMP9 | More | | Dexibuprofen | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Dexibuprofen | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Dexibuprofen | hsa04721 | Synaptic vesicle cycle | 3.09E-02 | 2 | Q99437, P43005 | ATP6V0B, SLC1A1 | More | | Dexibuprofen | hsa04724 | Glutamatergic synapse | 2.81E-02 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Dexibuprofen | hsa04725 | Cholinergic synapse | 3.86E-02 | 4 | P22694, Q14643, P18848, P10415 | PRKACB, ITPR1, ATF4, BCL2 | More | | Dexibuprofen | hsa04744 | Phototransduction | 2.80E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Dexibuprofen | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.05E-04 | 8 | P14778, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759 | IL1R1, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Dexibuprofen | hsa04915 | Estrogen signaling pathway | 2.25E-02 | 5 | P14780, P22694, P18848, Q14643, P10415 | MMP9, PRKACB, ATF4, ITPR1, BCL2 | More | | Dexibuprofen | hsa04916 | Melanogenesis | 4.80E-02 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Dexibuprofen | hsa04918 | Thyroid hormone synthesis | 2.91E-02 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | | Dexibuprofen | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Dexibuprofen | hsa04921 | Oxytocin signaling pathway | 3.51E-02 | 3 | Q15746, Q16566, Q8WYR1 | MYLK, CAMK4, PIK3R5 | More | | Dexibuprofen | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Dexibuprofen | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Dexibuprofen | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Dexibuprofen | hsa04927 | Cortisol synthesis and secretion | 7.04E-03 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Dexibuprofen | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.78E-03 | 5 | Q14643, P22694, P23771, P18848, P10415 | ITPR1, PRKACB, GATA3, ATF4, BCL2 | More | | Dexibuprofen | hsa04932 | Non-alcoholic fatty liver disease | 4.35E-04 | 7 | O43521, P18848, O75460, P01584, P13073, P12074, O15239 | BCL2L11, ATF4, ERN1, IL1B, COX4I1, COX6A1, NDUFA1 | More | | Dexibuprofen | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Dexibuprofen | hsa04934 | Cushing syndrome | 4.06E-02 | 5 | Q14643, P22694, P49841, Q9UJU2, O00170 | ITPR1, PRKACB, GSK3B, LEF1, AIP | More | | Dexibuprofen | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.68E-02 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Dexibuprofen | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Dexibuprofen | hsa04972 | Pancreatic secretion | 2.68E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Dexibuprofen | hsa04973 | Carbohydrate digestion and absorption | 1.66E-04 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Dexibuprofen | hsa05010 | Alzheimer disease | 2.21E-02 | 10 | O15239, P13073, P12074, Q00535, O75460, P0DP23, P01584, O95197, P67870, P28070 | NDUFA1, COX4I1, COX6A1, CDK5, ERN1, CALM1, IL1B, RTN3, CSNK2B, PSMB4 | More | | Dexibuprofen | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Dexibuprofen | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Dexibuprofen | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Dexibuprofen | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Dexibuprofen | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Dexibuprofen | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Dexibuprofen | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.86E-06 | 8 | Q99437, P09341, P19875, P10145, P19174, P25024, P25025, P07948 | ATP6V0B, CXCL1, CXCL2, IL8, PLCG1, CXCR1, CXCR2, LYN | More | | Dexibuprofen | hsa05130 | Pathogenic Escherichia coli infection | 2.94E-02 | 4 | Q14247, O00501, Q92974, P25116 | CTTN, CLDN5, ARHGEF2, F2R | More | | Dexibuprofen | hsa05132 | Salmonella infection | 1.10E-05 | 11 | P51617, Q9UJU2, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, LEF1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Dexibuprofen | hsa05134 | Legionellosis | 2.52E-05 | 6 | P01584, P11215, P68104, P11142, P09341, P19875 | IL1B, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | | Dexibuprofen | hsa05135 | Yersinia infection | 4.26E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | | Dexibuprofen | hsa05144 | Malaria | 1.45E-03 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Dexibuprofen | hsa05146 | Amoebiasis | 1.43E-11 | 13 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Dexibuprofen | hsa05150 | Staphylococcus aureus infection | 4.02E-03 | 6 | P21462, O75015, Q14532, P59665, P59666, P12838 | FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Dexibuprofen | hsa05152 | Tuberculosis | 3.22E-05 | 11 | Q13488, P0DP23, P48382, P25208, O60603, P01375, P10415, P13765, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, NFYB, TLR2, TNF, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | | Dexibuprofen | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Dexibuprofen | hsa05163 | Human cytomegalovirus infection | 2.14E-03 | 13 | P42338, P63218, P50151, P0DP23, Q8NHW4, Q08828, P23458, P01106, P14778, P01584, P61073, Q13651, P30101 | PIK3CB, GNG5, GNG10, CALM1, CCL4L2, ADCY1, JAK1, MYC, IL1R1, IL1B, CXCR4, IL10RA, PDIA3 | More | | Dexibuprofen | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.60E-03 | 8 | P42338, P63218, P50151, P09341, P19875, P19174, P07948, P01106 | PIK3CB, GNG5, GNG10, CXCL1, CXCL2, PLCG1, LYN, MYC | More | | Dexibuprofen | hsa05169 | Epstein-Barr virus infection | 1.27E-02 | 9 | P01106, Q13547, P42338, P07948, P30101, Q13761, O75293, P07766, P20963 | MYC, HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CD3E, CD247 | More | | Dexibuprofen | hsa05170 | Human immunodeficiency virus 1 infection | 5.17E-05 | 22 | P42338, P62873, P63218, P50151, P0DP23, P17252, Q13546, O00463, P30101, Q14643, P01568, P01730, P51617, O60603, Q13315, P19174, P23528, P07766, P20963, P10415, Q93034, Q9Y6Q5 | PIK3CB, GNB1, GNG5, GNG10, CALM1, PRKCA, RIPK1, TRAF5, PDIA3, ITPR1, IFNA21, CD4, IRAK1, TLR2, ATM, PLCG1, CFL1, CD3E, CD247, BCL2, CUL5, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51124 | GZMM | Granzyme M | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.834 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.701 | P51124 | GZMM | Granzyme M | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.845 | P51124 | GZMM | Granzyme M | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.804 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P17252 | PRKCA | Protein kinase C alpha type | 0.769 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.769 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | P51124 | GZMM | Granzyme M | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.846 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.823 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P01568 | IFNA21 | Interferon alpha-21 | 0.716 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.741 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | O60603 | TLR2 | Toll-like receptor 2 | -0.862 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13315 | ATM | Serine-protein kinase ATM | 0.758 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.94 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.946 |
| Dexibuprofen | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Dexibuprofen | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Dexibuprofen | hsa05202 | Transcriptional misregulation in cancer | 3.12E-07 | 17 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.794 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.795 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15532 | SS18 | Protein SSXT | 0.877 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q15532 | SS18 | Protein SSXT | 0.763 | P24158 | PRTN3 | Myeloblastin | Q15532 | SS18 | Protein SSXT | -0.732 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13315 | ATM | Serine-protein kinase ATM | 0.758 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.765 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.767 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.746 | P24158 | PRTN3 | Myeloblastin | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.837 | P08311 | CTSG | Cathepsin G | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.79 | P24158 | PRTN3 | Myeloblastin | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.735 | P08311 | CTSG | Cathepsin G | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.726 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14923 | JUP | Junction plakoglobin | 0.861 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P14923 | JUP | Junction plakoglobin | 0.845 | P24158 | PRTN3 | Myeloblastin | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.741 | P08311 | CTSG | Cathepsin G | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.909 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P24158 | PRTN3 | Myeloblastin | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.802 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.794 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.816 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.754 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O15550 | UTX | Lysine-specific demethylase 6A | -0.778 | P24158 | PRTN3 | Myeloblastin | O15550 | UTX | Lysine-specific demethylase 6A | 0.776 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.805 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.805 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P05164 | MPO | Myeloperoxidase | -0.758 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P24158 | PRTN3 | Myeloblastin | P05164 | MPO | Myeloperoxidase | 0.979 | P08311 | CTSG | Cathepsin G | P05164 | MPO | Myeloperoxidase | 0.956 | P08311 | CTSG | Cathepsin G | P12838 | DEFA4 | Neutrophil defensin 4 | 0.817 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P08246 | ELA2 | Neutrophil elastase | -0.942 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P08246 | ELA2 | Neutrophil elastase | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P24158 | PRTN3 | Myeloblastin | P08246 | ELA2 | Neutrophil elastase | 0.894 | P08311 | CTSG | Cathepsin G | P08246 | ELA2 | Neutrophil elastase | 0.792 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.766 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.787 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.879 | P24158 | PRTN3 | Myeloblastin | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.777 | P08311 | CTSG | Cathepsin G | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P24158 | PRTN3 | Myeloblastin | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.772 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 |
| Dexibuprofen | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Dexibuprofen | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Dexibuprofen | hsa05205 | Proteoglycans in cancer | 5.78E-04 | 10 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, WNT1, PTCH1, CD63 | More | | Dexibuprofen | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Dexibuprofen | hsa05217 | Basal cell carcinoma | 4.62E-03 | 5 | Q13635, P04628, P49841, Q9UJU2, P24522 | PTCH1, WNT1, GSK3B, LEF1, GADD45A | More | | Dexibuprofen | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Dexibuprofen | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.84E-07 | 12 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Dexibuprofen | hsa05310 | Asthma | 5.72E-05 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Dexibuprofen | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Dexibuprofen | hsa05321 | Inflammatory bowel disease | 3.03E-10 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Dexibuprofen | hsa05322 | Systemic lupus erythematosus | 6.60E-06 | 12 | P08246, P08311, P09871, P01375, P13765, P29965, Q93077, P62807, Q16778, O60814, P68431, P12814 | ELA2, CTSG, C1S, TNF, HLA-DOB, CD40LG, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1 | More | | Dexibuprofen | hsa05323 | Rheumatoid arthritis | 1.09E-03 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Dexibuprofen | hsa05332 | Graft-versus-host disease | 7.27E-07 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Dexibuprofen | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | |